Review Article

Advantages of Phosphodiesterase Type 5 Inhibitors in the Management of Glucose Metabolism Disorders: A Clinical and Translational Issue

Figure 2

Pivotal roles of PDE5i in glucose metabolic disorders. Schematic image summarizing the main effects of PDE5 inhibitors in insulin resistance and diabetes. LDL: low-density lipoprotein and T2DM: type 2 diabetes mellitus.